Literature DB >> 19846638

Subtyping of emm1 group A Streptococci causing invasive infections in France.

P Bidet1, E Lesteven, C Doit, S Liguori, P Mariani-Kurkdjian, S Bonacorsi, E Bingen.   

Abstract

By combining PCR amplification of toxin-encoding genes and sic gene sequencing, we distinguished 24 genotypes among 47 M/emm1 group A streptococci isolated from children and adults in France in 9 cases of infection comprising four clusters and 38 unrelated invasive infection cases used as controls.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19846638      PMCID： PMC2786636          DOI： 10.1128/JCM.00866-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone.

Authors:  M C Enright; B G Spratt; A Kalia; J H Cross; D E Bessen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children.

Authors:  Philippe Bidet; Céline Courroux; Christophe Salgueiro; Agnès Carol; Patricia Mariani-Kurkdjian; Stéphane Bonacorsi; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

3.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci.

Authors:  B Beall; R Facklam; T Thompson
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

4.  Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease.

Authors:  J Stanley; D Linton; M Desai; A Efstratiou; R George
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

Review 5.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 6.  Group A streptococci in the 1990s.

Authors:  A Efstratiou
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

7.  Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function.

Authors:  P Akesson; A G Sjöholm; L Björck
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

8.  Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children.

Authors:  Philippe Minodier; Philippe Bidet; Fabien Rallu; Bruce Tapiero; Edouard Bingen; Philippe Ovetchkine
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

9.  Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Authors:  Bogdan Luca-Harari; Jessica Darenberg; Shona Neal; Tuula Siljander; Lenka Strakova; Asha Tanna; Roberta Creti; Kim Ekelund; Maria Koliou; Panayotis T Tassios; Mark van der Linden; Monica Straut; Jaana Vuopio-Varkila; Anne Bouvet; Androulla Efstratiou; Claes Schalén; Birgitta Henriques-Normark; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

10.  Relationships between emm and multilocus sequence types within a global collection of Streptococcus pyogenes.

Authors:  Debra E Bessen; Karen F McGregor; Adrian M Whatmore
Journal:  BMC Microbiol       Date:  2008-04-11       Impact factor: 3.605
View more
  2 in total

Review 1.  Current insights in invasive group A streptococcal infections in pediatrics.

Authors:  Anne Filleron; Eric Jeziorski; Anne-Laure Michon; Michel Rodière; Hélène Marchandin
Journal:  Eur J Pediatr       Date:  2012-02-25       Impact factor: 3.183

2.  Integration of Genomic and Other Epidemiologic Data to Investigate and Control a Cross-Institutional Outbreak of Streptococcus pyogenes.

Authors:  Victoria J Chalker; Alyson Smith; Ali Al-Shahib; Stella Botchway; Emily Macdonald; Roger Daniel; Sarah Phillips; Steven Platt; Michel Doumith; Rediat Tewolde; Juliana Coelho; Keith A Jolley; Anthony Underwood; Noel D McCarthy
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.